3-Formyl-2-hydroxybenzoic Acid - CAS 610-04-8
Catalog: |
BB030894 |
Product Name: |
3-Formyl-2-hydroxybenzoic Acid |
CAS: |
610-04-8 |
Synonyms: |
3-formyl-2-hydroxybenzoic acid; 3-formyl-2-hydroxybenzoic acid |
IUPAC Name: | 3-formyl-2-hydroxybenzoic acid |
Description: | 3-Formylsalicylic acid is a non-competitive inhibitor of estrone sulfatase (IC50 = 150 nM; Ki = 120 nM), the enzyme that converts estrone sulfate to estrone. |
Molecular Weight: | 166.13 |
Molecular Formula: | C8H6O4 |
Canonical SMILES: | C1=CC(=C(C(=C1)C(=O)O)O)C=O |
InChI: | InChI=1S/C8H6O4/c9-4-5-2-1-3-6(7(5)10)8(11)12/h1-4,10H,(H,11,12) |
InChI Key: | YOEUNKPREOJHBW-UHFFFAOYSA-N |
Boiling Point: | 306.9 °C at 760 mmHg |
Purity: | > 98 % |
Density: | 1.482 g/cm3 |
Appearance: | Crystalline solid |
LogP: | 0.90290 |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P264, P270, P280, P301+P312, P305+P351+P338, P330, P337+P313, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2021050688-A1 | Compounds and uses thereof | 20190910 |
WO-2020187955-A1 | Use of an agent capable of inhibiting the activation of mait cells for the treatment of obesity and obesity-related disorders | 20190319 |
WO-2020153431-A1 | Ester compound | 20190124 |
WO-2020080957-A1 | Methods of treating or preventing skin conditions | 20181019 |
EP-3641802-A1 | Methods and pharmaceutical compositions for the treatment of fibrosis with agents capable of inhibiting the activation of mucosal-associated invariant t (mait) cells | 20170622 |
PMID | Publication Date | Title | Journal |
22409581 | 20120402 | Dodecanuclear [Cu(II)6Gd(III)6] nanoclusters as magnetic refrigerants | Inorganic chemistry |
21060953 | 20110107 | New cyclometallated precursors of unsubstituted N-phenylpyrazole [{Pd(phpz)(μ-X)}2] (X = AcO or OH) and study of their reactivity towards selected ligands | Dalton transactions (Cambridge, England : 2003) |
21123892 | 20101201 | 5-Formylsalicylic acid and 5-(benzimidazolium-2-yl)salicylate | Acta crystallographica. Section C, Crystal structure communications |
20565084 | 20100719 | Polymer-bound oxidovanadium(IV) and dioxidovanadium(V) complexes as catalysts for the oxidative desulfurization of model fuel diesel | Inorganic chemistry |
20044303 | 20100201 | Spectroscopic studies on 3- and 5-formylsalicylic acids and their complexes with Fe(III) | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy |
Complexity: | 190 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 166.02660867 |
Formal Charge: | 0 |
Heavy Atom Count: | 12 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 166.02660867 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 74.6 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Carbonyl Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS